We are an established leader in both the modulation of pharmacokinetics to achieve tailored modified or targeted delivery, and in the application of specialized liquid-filled hard capsule technology. Colonic drug delivery is historically utilized to treat colon-specific diseases such as irritable bowel syndrome, but is also increasingly explored for other therapeutic applications, taking advantage of the colon’s extensive absorptive surface area.
We combine our expertise in encapsulation and targeted delivery to the gastro-intestinal track to achieve effective colonic delivery. The utilization of liquid-filled hard capsule technology in targeting the colon has received increased attention for the treatment of colon-specific and other indications. We provide integrated service options for colonic drug delivery, inclusive of API and finished liquid-filled hard capsule drug product development and manufacturing.